Chemistry, Biological Properties, and Bio-Analysis of Tafamidis, a New Transthyretin Stabilizer: A Systematic Review

Cardiomyopathy is a global health crisis that affects people all over the world. Consequently, scientists felt compelled to look for and develop ever-more-powerful pharmaceuticals. For ATTR-CM, the only drug currently recommended by the European Society of Cardiology is Tafamidis.